Human enteroendocrine cell responses to infection with Chlamydia trachomatis: a microarray study by Aldona Dlugosz et al.
Dlugosz et al. Gut Pathogens 2014, 6:24
http://www.gutpathogens.com/content/6/1/24RESEARCH Open AccessHuman enteroendocrine cell responses to
infection with Chlamydia trachomatis: a microarray
study
Aldona Dlugosz1*, Sandra Muschiol2, Katherina Zakikhany3, Ghazaleh Assadi4, Mauro D’Amato4
and Greger Lindberg1Abstract
Background: Enteroendocrine cells (EEC) are highly specialized cells producing signalling molecules vital to the
normal functions of the gut. Recently, we showed altered protein distribution in Chlamydia infected EEC in vitro.
The aim of this study was to perform a microarray analysis of the response pattern of EEC from both large and
small bowel to infection in vitro, using Chlamydia trachomatis infection as a model.
Methods: Two human EEC lines: LCC-18, derived from a neuroendocrine colonic tumour, and CNDT-2, derived from
a small intestinal carcinoid, were infected using cultured C. trachomatis serovar LGV II strain 434 (ATCC VR-902B).
Penicillin G was used to induce persistent infection. We used microarray analysis (Affymetrix GeneChip®) for studying
changes in gene expression at different stages of infection.
Results: Twenty-four hours after active and persistent infection, 66 and 411 genes in LCC-18 and 68 and 170 genes in
CNDT-2 cells, respectively showed mean expression ratios >2-fold compared to non-infected cells. These genes
encoded factors regulating apoptosis, cell differentiation, transcription regulation, cytokine activity, amine biosynthesis
and vesicular transport. We found significant differences in gene transcription levels between persistently infected and
non-infected cells in 10 genes coding for different solute carrier transporters (SLC) and in 5 genes related to endocrine
function (GABARAPL1, GRIP1, DRD2, SYT5 and SYT7).
Conclusions: Infected EEC cells exhibit cell-type specific patterns related to vesicular transport, secretion and
neurotransmitters. EEC play a pivotal role in regulation of gut motility and an impairment of enteroendocrine function
can contribute to motility disorders.
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Enteroendocrine cells (EEC) are present in the gastro-
intestinal (GI) tract (mucosa of the stomach, small intes-
tine, colon, and rectum) and are highly specialized cells
that produce hormones and other signalling substances
that are vital to the normal function of the gut. Due to
their diffuse localisation, EEC are difficult to study and
so far, their role in the pathogenesis of bowel disorders
has been only little explored. EEC play a pivotal role in* Correspondence: aldona.dlugosz@karolinska.se
1Karolinska Institutet, Department of Medicine, Division of Gastroenterology
and Hepatology, Karolinska University Hospital, Gastrocentrum Huddinge
K63, Stockholm, Sweden
Full list of author information is available at the end of the article
© 2014 Dlugosz et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.sensory signalling for the enteric reflex regulating intes-
tinal propulsive motility, secretion, and visceral hyperalge-
sia [1]. Alteration of endocrine cell function, particularly
in the context of serotonin (5-HT), has been shown to be
associated in a number of GI diseases including inflam-
matory bowel disease (IBD), coeliac disease and irritable
bowel syndrome (IBS) [2-4]. The association between
alterations in the production of gut hormones from EEC
and various GI diseases emphasizes the significance of
these cells in intestinal homeostasis.
EEC can be activated by bacterial ligands like lipopolysac-
charide LPS [5] and may play a role in immune activation
and in the regulation of gut inflammation. Altered endo-
crine function of the gut accompanies an inflammatoryl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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serotonin and chromogranin-A distribution in EEC infected
with Chlamydia trachomatis [7]. In line with the micro-
scopical findings, we found a significant down-regulation of
the gene coding for the vesicular monoamine transporter
(VMAT1) in infected compared with non-infected EEC
(P < 0.05). Bacteria of the genus Chlamydia are gram-
negative, obligate intracellular pathogens that can infect a
wide range of eukaryotic cells and cause chronic and acute
diseases in humans and animals. All Chlamydia species
share a common biphasic developmental cycle in which the
organism alternates between two developmental forms, the
elementary body (EB), the infectious form of the organism
and the reticulate body (RB), the metabolically active but
non-infectious form of the bacterium. Upon attachment
and internalization, EBs differentiate into RBs, that multiply
inside a membrane-bound vacuole termed inclusion.Figure 1 LCC-18 and CNDT-2 cells actively and persistently infected w
through inclusions containing both elementary bodies (EB) and reticulate b
lines. In EEC treated with penicillin G enlarged, aberrant bacteria (arrows) reRBs eventually differentiate back into EBs, which upon
their exit from the host cell can start a new round of infec-
tion. In addition to such acute chlamydial infection,
Chlamydia can persist within infected host cells, a condi-
tion that has been associated with a number of chronic
diseases. Chlamydial persistence has been described as a
viable but non-cultivable growth stage resulting in a long-
term relationship with the infected host cell. Such rela-
tionships can be established in vitro through exposure to
antibiotics [8].
The aim of this study was to evaluate the response
pattern of enteroendocrine cells to intracellular bacteria
in vitro using microarray technology. Based on previous
results from our laboratory we used C. trachomatis as the
infectious agent for studying gene expression alterations
upon bacterial infection of EEC (2). Analysis of genome-
wide expression patterns on the host during infectionith Chlamydia trachomatis L2. Growth of C. trachomatis, manifested
odies (RB) at 24 h post infection (p.i.), could be observed in both cell
miniscent of persistent growth forms can be seen.
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process a pathogen [9]. We assessed transcription profiles
of EEC lines from both the large bowel and the small
bowel after infection with C. trachomatis.Results
With TEM we confirmed active and persistent infection
caused by C. trachomatis in enteroendocrine cells, ori-
ginating from both large and small bowel. As shown in
Figure 1, growth of C. trachomatis, manifested through
inclusions containing both elementary bodies (EB) and
reticulate bodies (RB) at 24 h post infection (p.i.), could
be observed for both cell lines. When EECs were treated
with penG we observed enlarged, aberrant bacteria rem-
iniscent of persistent growth forms.
In order to screen host-cell gene regulation in response
to C. trachomatis infection we used microarrays repre-
senting 30 000 human genes. We studied gene changes
(up or down regulation) at the same time point (24 h post
infection) in both active and persistent infection. The time
point at 24 h was chosen as it represents a period of active
metabolism and binary fission of C. trachomatis reticulate
bodies within the host cell.Cell line specific responses to C. trachomatis active and
persistent infection
We identified 66 differentially transcribed genes or
expressed sequence tags (ESTs) (61 up-regulated) in
LCC-18 cells with active C.trachomatis infection com-
pared to non-infected cells and 411 (108 up-regulated)
in persistently infected LCC-18 cells compared to non-
infected cells. Twelve differentially transcribed genes (11
up-regulated) were identical for both active and persist-
ent infection of LCC-18 cells. In order to identify differ-
ent gene clusters among differentially transcribed genes
we employed the DAVID Functional Annotation Tool.
Based on this analysis four main clusters encoding genes
involved in apoptosis GO:0006915, transcription regula-
tion activity GO:0045449, vesicle mediated transport
GO:0016192 and group of genes intrinsic to membrane
GO:0031224 were identified.
In CNDT-2 cells, we identified 68 differentially tran-
scribed genes or expressed sequence tags (ESTs) when
infected with C. trachomatis (58 up-regulated) and re-
spectively 170 differentially transcribed genes or ESTs
(120 up-regulated) in persistently infected CNDT-2 cells
compared to non infected cells. Thirty-nine differentially
transcribed genes (all up-regulated) were identical for both
active and persistent infection of CNDT-2 cells. Genes were
grouped in 8 clusters (amine biosynthesis GO:0009309,
apoptosis GO:0006915, intracellular organelle lumen
GO:0070013, plasma membrane GO:0005886, ion-binding
GO:0043167, transcription regulator activity GO:0045449,intracellular non-membrane-bounded organelle GO:0043232,
amino-acid transporter activity GO:0015171) (Figure 2).
Tables 1, 2, 3 and 4 show the most prominent differen-
tially transcribed genes in the two cell lines. The pre-
sented genes are up or down-regulated by >3 fold in
studied cell lines.
Gene signatures of active and persistent
C. trachomatis infection
Host responses to infection in the two cell lines during
active chlamydial infection were similar. Only 8 differen-
tially transcribed genes (6 up-regulated) were the same
for both CNDT-2 and LCC-18 cell lines. Differentially
transcribed gene clusters comprised genes involved in
apoptosis GO:000006915, negative regulation of cell
communication GO:0010648, ion binding GO:0043167,
cellular protein catabolic process GO:0005886, cell cycle
GO:0007048, membrane enclosed lumen GO:0031974,
cytokine activity GO:0005125, and vesicle mediated
transport GO:0016192.
In persistent infection we found 44 differentially tran-
scribed genes (18 up-regulated and 26 down-regulated)
in both CNDT-2 and LCC-18 cells. Among them were
genes involved in apoptosis GO:0006915, cytokine activ-
ity GO:0005125, growth factor activity GO:0008083, cell
cycle GO:0007049, DNA metabolic process GO:0006259,
intracellular organelle lumen GO:0070013, amine bio-
synthesis GO:0009309, transcription regulation activity
GO:0045449, cell-cell signalling GO:0007267, regulation of
phosphorylation GO:0042325, ion binding GO:0043167,
and plasma membrane GO:0005886 (Figure 2). The
remaining differentially transcribed genes in persistent in-
fection were involved in immune response GO:0006955,
vesicle lumen GO:0031983, cytoplasmic vesicle GO:0031410,
vesicle mediated transport GO:0016192, intrinsic to
membrane GO:0031224 and regulation of cell motion
GO:0051270 (Figure 2).
Baculoviral IAP repeat-containing 3 (BIRC3) was the
only gene that was up-regulated in both cell lines during
active and persistent infection.
Selected genes of interest
Grouping of particular genes into specific functional
classes is arbitrary to a certain degree, because some
genes may be involved in several cellular functions and
pathways. In order to study cell type-specific responses
to infection, we analyzed the expression of genes associ-
ated with transport and endocrine function.
We found significant differences in the gene transcrip-
tion levels between persistently infected and non-infected
cells of 10 genes coding for different solute carrier trans-
porters (SLC) (Table 5).
We also found significant differences in the expression of
genes related to glutamate transport and synthesis: SLC1A4,
Figure 2 Cell line specific responses and gene signatures of active and persistent C. trachomatis infection. A. Differentially transcribed
genes (up or down-regulated by >2-fold) in active (AI) or persistent (PI) infection of LCC-18 and CNDT-2 cells compared to non-infected cells (NI). We
identified 66 differentially transcribed genes (61 up-regulated) in LCC-18 cells with active C. trachomatis infection compared to non-infected cells and
411 (108 up-regulated) in persistently infected LCC-18 cells compared to non-infected cells. Twelve differentially transcribed genes (11 up-regulated)
were identical for both active and persistent infection of LCC-18 cells. In CNDT-2 cells, we identified 68 differentially transcribed genes when infected
with C. trachomatis (58 up-regulated) and respectively 170 differentially transcribed genes or ESTs (120 up-regulated) in persistently infected CNDT-2
cells compared to non infected cells. Thirty-nine differentially transcribed genes (all up-regulated) were identical for both active and persistent infection
of CNDT-2 cells. Baculoviral IAP repeat-containing 3 (BIRC3) was the only gene that was up-regulated in both cell lines during active and persistent
infection. B. Schematic presentation of differentially transcribed genes clusters in active (AI) and persistent (PI) infection compared to non-infected cells
(NI) in LCC-18 and CNDT-2 cells. Gene clustering based on Gene Ontology (GO) was performed using the Database for Annotation, Visualization and
Integrated Discovery (DAVID) (http://david.abcc.ncifcrf.gov).
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tamate receptor interacting protein 1 (GRIP 1) were up-
regulated in persistently infected cells compared to
non-infected cells. We identified 5 genes related to
endocrine function that were differentially transcribed
in persistent infection compared to non-infected cells
but we found differences between studied cell lines.
GABARAPL1 and SYT5 were up-regulated in both cell
lines whereas GRIP1, DRD2, and SYT7 were differen-
tially transcribed only in LCC-18 cells (Table 6).
Although many similarities were found between the
two cell lines we also found many differences in the
response to infection. Some of these could be due to
differences in basal gene transcription between the two
studied cell lines. For example, basal expressions of
receptors for gamma-aminobutyric acid: (GABA)A
receptor, alpha 1 (GABRA1), (GABA)A receptor, alpha 3
(GABRA3), (GABA)A receptor, beta 2 (GABRB2) and
(GABA)B receptor 1 (GABBR1) were significantly lower
in CNDT-2 than in LCC-18, whereas (GABA)A receptor-
associated protein like 1 (GABARAPL1) expression was
lower in LCC-18 cells (data available at http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE58151).Confirmation using qPCR
The changes in expression of selected genes were vali-
dated by qPCR (Table 5). This process validated 10
genes coding for different solute carrier transporters
(SLC1A4, SLC5A3, SLC7A5, SLC7A11, SLC16A6,
SLC25A10, SLC25A35, SLC35D2, SLC38A4, SLC41A2).
The changes in the expression levels of the validated
genes between persistently infected and non-infected
cells were paralleled in microarray and qPCR experi-
ments in both cell lines.
Discussion
Several studies have described Chlamydia-induced tran-
scriptome changes in epithelial cells [10-12]. Our study
is the first to describe such changes in enteroendocrine
cells. Studying EEC response to infection seems to be
very important since the adult human intestine is home
to between 1000 and 1150 prevalent bacterial species
[13]. The role of EEC in immune activation and promo-
tion of inflammation in the gut has been postulated be-
fore [14-16]. A recent study showed that regenerating
islet-derived gene REG4 coding for protein associated
with epithelial inflammation was expressed in serotonin-
Table 1 Differentially transcribed host genes up or down-regulated by >3-fold at 24 h after C. trachomatis infection of
CNDT-2 cells compared to non-infected




8102800 Solute carrier family 7, (cationic amino acid transporter, y + system) member 11 SLC7A11 3,50 11,28
8154381 Chromosome 9 open reading frame 150 C9orf150 3,25 9,51
7982868 ChaC, cation transport regulator homolog 1 (E. coli) CHAC1 2,63 6,18
7928308 DNA-damage-inducible transcript 4 DDIT4 2,41 5,33
7902290 Hystathionase (cystathionine gamma-lyase) CTH 1,89 3,72





8166585 Hypothetical locus FLJ32742 FLJ32742 1,77 3,41
7920873 Small nucleolar RNA, H/ACA box 42 SNORA42 1,74 3,35
7899436 Sestrin 2 SESN2 1,66 3,17
8139737 Phosphoserine phosphatase PSPH 1,66 3,17
8060344 Tribbles homolog 3 (Drosophila) TRIB3 1,62 3,08
8122724 UL16 binding protein 1 ULBP1 1,61 3,06
8143341 Jumonji C domain containing histone demethylase 1 homolog D
(S. cerevisiae)
JHDM1D 1,61 3,06
8084219 Kelch-like 24 (Drosophila) KLHL24 1,59 3,03
Presented genes are involved in cellular amino-acid biosynthesis, stress response, carboxylic and organic acid biosynthetic process, amine biosynthetic process.
Gene clustering based on Gene Ontology identified two clusters: apoptosis and ion binding.
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thelial cells of the upper colonic crypts during inflamma-
tion [17]. Alterations in the number of EEC have been
observed in response to different bacterial, viral and
parasitic infections of the GI tract [18,19] but the impact
of a bacterial infection on EEC themselves has never
been studied. Previous studies on Chlamydia infection
of epithelial cells showed alterations in genes encoding
apoptosis inhibitors, regulators of cell differentiation,
components of the cytoskeleton, transcription factors,
proinflammatory cytokines and cellular growth factors
and cell cycle [18,20,21]. Our results showed that the
impact of Chlamydia infection on apoptosis (BIRC3,Table 2 Differentially transcribed host genes up or down-reg
LCC-18 cells compared to non-infected
Affymetrix ID Gene name
7943413 Baculoviral IAP repeat-containing 3
8124650 Ubiquitin D /// gamma-aminobutyric acid (GABA) B recept
8178295
7954090 Epithelial membrane protein 1
8122265 Tumor necrosis factor, alpha-induced protein 3
7984259 RNA, U5B small nuclear 1
7908072 Laminin, gamma 2
Gene clustering based on Gene Ontology identified two clusters: apoptosis and celEMP1, CHAC1), immune response, host cell structure
and cell cycle in EEC is similar to what has been ob-
served in epithelial cells [21,22].
The expression of BIRC3 (also known as cIAP2 or
HIAP) [23], an apoptotic suppressor, was up-regulated in
both cell lines during active and persistent infection.
BIRC 3 is a component of the tumour necrosis factor re-
ceptor 2 (TNFR2) complex and, therefore, is a constitu-
ent of the TNF alpha (TNFα) signalling pathway [24].
BIRC3 has been demonstrated to inhibit cell death by
directly repressing the proapoptotic activity of a family
of cysteine proteases, caspases, as well as targeting proa-
poptotic components of the TNFα signalling pathway forulated by >3-fold at 24 h after C. trachomatis infection of
Gene symbol Log2 fold change Absolute fold change
BIRC3 2,14 4,41





lular protein catabolic process.
Table 3 Differentially transcribed host genes up or down-regulated by >3-fold at 24 h after C. trachomatis persistent
infection of CNDT-2 cells compared to non-infected






8102800 Solute carrier family 7, (cationic amino acid transporter, y + system) member 11 SLC7A11 3,77 13,56
7982868 ChaC, cation transport regulator homolog 1 (E. coli) CHAC1 3,28 9,71
7928308 DNA-damage-inducible transcript 4 DDIT4 2,47 5,55
8146934 Lymphocyte antigen 96 LY96 2,09 4,26
8154381 Chromosome 9 open reading frame 150 C9orf150 1,96 3,89
8143341 Jumonji C domain containing histone demethylase 1 homolog D
(S. cerevisiae)
JHDM1D 1,93 3,81
8122724 UL16 binding protein 1 ULBP1 1,85 3,61
8174361 TSC22 domain family, member 3 TSC22D3 1,75 3,36
8122202 v-myb myeloblastosis viral oncogene homolog (avian) MYB −1,73 3,31
7912157 ERBB receptor feedback inhibitor 1 ERRFI1 1,71 3,27
8156043 Phosphoserine aminotransferase 1 PSAT1 1,71 3,27
8139737 Phosphoserine phosphatase PSPH 1,70 3,26
7899436 Sestrin 2 SESN2 1,65 3,14
7902290 Cystathionase (cystathionine gamma-lyase) CTH 1,59 3,02
8049542 Leucine rich repeat (in FLII) interacting protein 1 LRRFIP1 1,59 3,00
Gene clustering based on Gene Ontology identified five clusters: amine biosynthesis, apoptosis, transcription regulator activity, intrinsic to membrane and
ion binding.
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tion with Chlamydia protects mammalian host cells
against apoptosis via BIRC3 up-regulation [26,27]. Inhib-
ition of apoptosis and cytoskeleton modifications pos-
sibly accommodate chlamydial growth [9].
The ability of Chlamydiae to alter host cell proliferation
and differentiation was manifested by up-regulation of
growth factors: growth differentiation factor 15 (GDF15),
vascular endothelial growth factor A (VEGFA), amphire-
gulin (AREG) and transforming growth factor beta 2
(TGFΒ2). GDF15 was the most up-regulated gene in per-
sistently infected LCC-18 cells (>10 fold change). GDF15
is a member of the TGFB family with a capacity to inhibit
LPS-induced macrophage activation. GDF15 also provide
significant neuroprotection with prominent effects on
dopaminergic and serotonergic neurons [28].
The innate response upon Chlamydia infection of
EEC is mediated by Toll-like receptor 4 (TLR4). TLR4
was up-regulated in LCC-18 and lymphocyte antigen 96
(LY96) was up-regulated in CNDT-2. LY96 encodes a
protein, which associates with TLR 4 on the cell surface
and confers responsiveness to LPS, thus providing a link
between the receptor and LPS signalling.
Besides similarities in host-pathogen interaction be-
tween EEC and epithelial cells we found changes in gene
expression in EEC that have never been described in epi-
thelial cells. We found significant differences in gene tran-
scription between persistently infected and non-infected
cells in 10 genes coding for different solute carriertransporters (SLC) (Table 5). Transporters are the gate-
keepers for all cells and organelles, controlling uptake and
efflux of crucial compounds such as sugars, amino acids,
nucleotides, inorganic ions and drugs. The SLC family
include genes encoding passive transporters, ion
coupled transporters and exchangers [29]. The biggest
expression change was found for SLC7A11 in CNDT-2
cells (>13-fold). SLC7A11 is responsible for a sodium-
independent, high-affinity exchange of anionic amino acids
with high specificity for anionic forms of cysteine and glu-
tamate. Up-regulation of SLC7A11 was previously reported
in small bowel mucosa during cholera infection [30].
In addition to up-regulation of genes coding for two
transporters involved in glutamate transport (SLC7A11
and SLC1A4) we also found significant differences in the
expression of other genes related to glutamate signalling
(argininosuccinate synthetase 1 (ASS1) and glutamate re-
ceptor interacting protein 1(GRIP 1)) in persistently in-
fected LCC-18 cells compared to non-infected cells.
GABAA receptor-associated protein like 1 (GABARAPL1)
was up-regulated during persistent infection in both cell
lines. Glutamate and GABA (γ-aminobutyric acid) are the
major neurotransmitters acting on specific G-protein-
coupled receptors (the metabotropic glutamate (mGlu)
and GABAB receptors) to modulate synaptic transport.
EEC provide an important link in transfer of informa-
tion between gut and brain. Primary afferent neurons are
excited indirectly by serotonine or hormones released
from EEC. Sensory information from the gastrointestinal
Table 4 Differentially transcribed host genes up or down-regulated by >3-fold at 24 h after C. trachomatis persistent
infection of LCC-18 cells compared to non-infected
Affymetrix
ID




8027002 Growth differentiation factor 15 GDF15 3,32 10,01
7958262 t-complex 11 (mouse)-like 2 TCP11L2 2,96 7,79
7954090 Epithelial membrane protein 1 EMP1 2,59 6,03
8158671 Argininosuccinate synthetase 1 ASS1 2,10 4,29
8152703 F-box protein 32 FBXO32 2,09 4,25
7982868 ChaC, cation transport regulator homolog 1 (E. coli) CHAC1 2,09 4,25
8048319 Villin 1 VIL1 −2,04 4,10
8066431 Adenosine deaminase ADA −2,00 3,99
8008885 microRNA 21 MIR21 1,99 3,96
8034122 SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) SPC24 −1,96 3,89
8119898 Vascular endothelial growth factor A VEGFA 1,91 3,77
8117429 Histone cluster 1, H2bi HIST1H2BI −1,88 3,69
7919591 Family with sequence similarity 72, member D /// family with sequence
similarity 72,
FAM72D / FAM72A /
FAM72B / FAM72C
−1,84 3,60
8122724 UL16 binding protein 1 ULBP1 1,81 3,49
8007071 Cell division cycle 6 homolog (S. cerevisiae) CDC6 −1,80 3,49
8113073 Arrestin domain containing 3 ARRDC3 1,79 3,45
8068684 Family with sequence similarity 3, member B FAM3B −1,76 3,40
7989146 Meiosis-specific nuclear structural 1 MNS1 −1,70 3,24
8109712 Hyaluronan-mediated motility receptor (RHAMM) HMMR −1,68 3,20
8113278 Lix1 homolog (chicken) LIX1 −1,66 3,15
7953943 GABA(A) receptor-associated protein like 1 GABARAPL1 1,65 3,15
8071212 CDC45 cell division cycle 45-like (S. cerevisiae) CDC45L −1,65 3,14
8009243 Chromosome 17 open reading frame 60 C17orf60 1,65 3,13
8062064 Myosin, heavy chain 7B, cardiac muscle, beta MYH7B −1,64 3,11
8021470 Phorbol-12-myristate-13-acetate-induced protein 1 PMAIP1 1,62 3,08
8095744 Amphiregulin AREG 1,62 3,08
7989647 KIAA0101 /// casein kinase 1, gamma 1 KIAA0101 /// CSNK1G1 −1,61 3,06
7914878 Arsenic transactivated protein 1 LOC100289612 −1,61 3,05
8165663 Glycerol-3-phosphate acyltransferase, mitochondrial GPAM −1,60 3,04
8077731 Fanconi anemia, complementation group D2 FANCD2 −1,59 3,03
8151871 Cyclin E2 CCNE2 −1,59 3,03
8157524 Toll-like receptor 4 TLR4 1,59 3,03
8104234 Thyroid hormone receptor interactor 13 TRIP13 −1,59 3,01
Gene clustering based on Gene Ontology identified ten clusters: cell cycle, cell surface, regulation of apoptosis, organelle lumen, cytoskeleton, immune response,
regulation of phosphorylation, cytokine activity, intrinsic to membrane and ion binding.
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of the nucleus tractus solitarius, which integrate this sen-
sory information to regulate autonomic functions and
homeostasis. The integrated response is conveyed to the
preganglionic neurons of the dorsal motor nucleus of the
vagus using mainly GABA, glutamate and catecholamines
as neurotransmitters [31]. Glutamate is involved in the
regulation of gut motility and secretion by acting as anexcitatory neurotransmitter in the gut [32]. Changes in
glutamate related gene expression could be beneficial to
Chlamydia. It was shown that glutamate could support
chlamydial growth [33]. Ojcius et al. [34] demonstrated
the stimulation of glutamate synthesis in cells infected
with Chlamydia psittaci.
Genes associated with glutamate transport (SLC7A11,
SLC1A4) were up-regulated in CNDT-2 cells and ASS1,
Table 5 Differentially transcribed genes coding for solute carrier families (SLC), up or down-regulated at 24 h after C.
trachomatis persistent infection of CNDT-2 and LCC-18 cells compared to non-infected










LCC-18 LCC-18 CNDT-2 CNDT-2









8042310 Solute carrier family 1 (glutamate/neutral
amino acid transporter), member 4
SLC1A4 NC NC 1,37 2,58
0,94 1,9 1,12 2,2
8068361 Solute carrier family 5 (sodium/myo-inositol
cotransporter), member 3
SLC5A3 1,2 2,3 NC NC
1,28 2,4 0,18 1,1
8003298 Solute carrier family 7 (cationic amino acid
transporter, y + system), member 5
SLC7A5 NC NC 1,26 2,4
−0,6 1,4 0,48 1,4
8102800 Solute carrier family 7, (cationic amino acid
transporter, y + system) member 11
SLC7A11 0,84 1,8 3,76 13,6
1,63 3,1 1.55 2,9
8017843 Solute carrier family 16, member 6
(monocarboxylic acid transporter 7
SLC16A6 1,26 2,4 0,88 1,8
0,68 1,6 1,67 3,2
8010673 Solute carrier family 25 (mitochondrial carrier;
dicarboxylate transporter), member 10
SLC25A10 −0,79 1,7 −1,07 2,1
−0,11 1,1 −1,49 2,5
8012450 Solute carrier family 25, member 35 SLC25A35 −0,96 2 −0,43 1,4
−0,49 1,4 −0,79 1,7
8162586 Solute carrier family 35,member D2 UDP-
N-acetylglucosamine/UDP-glucose/GDP-
mannose transporter
SLC35D2 0,96 2 0,57 1,5
0,74 1,7 0,8 1,7
7962559 Solute carrier family 38, member 4,
Na(+)-coupled neutral
amino acid transporter
SLC38A4 1,48 2,8 −1,1 2,2
0,92 1,9 −0,56 1,4
7965964 Solute carrier family 41, member 2,
plasma-membrane magnesium transporter
SLC41A2 0,4 1,3 1,18 2,3
0,45 1,4 1,62 3,1
A fold change > 2 was observed in at least one comparison. Microarray results and validation of candidate genes using qPCR.
PI = persistent infection, NI = non-infected cells. Log2 fold change “-“ = down- regulated,“+” = up-regulated. NC = no change.
Table 6 Differentially transcribed genes related to EEC function, up or down-regulated at 24 h after C. trachomatis
persistent infection of CNDT-2 and LCC-18 cells compared to non-infected










LCC-18 LCC-18 CNDT-2 CNDT-2
PI v NI PI v NI PI v NI PI v NI
7953943 GABA(A) receptor-associated protein like 1 GABARAPL 1,65 3,2 1,10 2,0
7964759 glutamate receptor interacting protein 1 GRIP1 1,14 2,2 NC NC
7951703 Dopamine receptor 2 DRD2 1,02 2,0 NC NC
8039378 Synaptotagmin5 SYT5 1,3 2,5 0,54 1,5
7948588 Synaptotagmin7 SYT7 −1,15 2,1 NC NC
A fold change >2 was observed in at least one comparison. PI = persistent infection, NI = non- infected cells. Log2 fold change “-“ = down- regulated,
“+” = up-regulated. NC = no change.
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http://www.gutpathogens.com/content/6/1/24which is involved in glutamate synthesis [35] and GRIP1
were up-regulated in LCC-18 cells. GRIP1 is a synaptic
protein interacting with glutamate receptors, playing an
important role in their trafficking, synaptic targeting and
recycling. GABARAP involves GRIP1 in the regulation
of GABAA receptor function at inhibitory synapses [36].
GABA acts through a paracrine or autocrine mechan-
ism via GABAA receptor activation [37]. This agent may
play a similar role as a signalling molecule in endocrine
organs and can for example inhibit the serotonin secre-
tion [38]. The role of GABARAP binding proteins is not
restricted to GABAA receptor transport but they partici-
pate in multiple biological processes, such as general
vesicular transport and fusion events, autophagy and
apoptosis. GABARAP appears to be associated with
transport vesicles rather than the cell surface [39].
DRD2 gene, encodes the D2 subtype of the dopamine
receptor (another G-protein-coupled receptor), was up-
regulated in persistent infection in LCC-18 cells. Dopa-
mine (DA) is an enteric neurotransmitter and D2 seems
to be an important mediator of neuronal responses to
DA. Li et al. [40] showed that propulsive motility is in-
creased in the gut of mice that lack D2 receptors sug-
gesting that D2 is a major mediator of the effects of
endogenous DA in the enteric nervous system (ENS).
Synaptotagmins SYT5 and SYT7 are other endocrine
related genes that were differentially transcribed in persist-
ent infection of LCC-18. Neurotransmitters, neuropep-
tides and hormones are released through the regulated
exocytosis of SVs (synaptic vesicles) and LDCVs (large
dense-core vesicles), a process that is controlled by cal-
cium [41]. Ca2+ triggers many forms of exocytosis in dif-
ferent types of eukaryotic cells, for example synaptic
vesicle exocytosis in neurons, granule exocytosis in mast
cells, and hormone exocytosis in endocrine cells [42].
Synaptotagmins are a family of type-1-membrane proteins
that share a common domain structure. Most synaptotag-
mins are located in brain and endocrine cells, and some of
these synaptotagmins bind to phospholipids and calcium
at levels that trigger regulated exocytosis of SVs and
LDCVs [41]. Synaptotagmin 5 is a neuroendocrine cell-
specific synaptotagmin responsible for phospholipid bind-
ing. Synaptotagmin 7 is a major Ca2+-sensor in endocrine
LDCV exocytosis [42].
Our study provides new insights into the molecular
events taking place in Chlamydia infection of EEC. We
found that Chlamydia infected EEC may share some
gene expression patterns with infected epithelial cells but
they also seem to have some cell type-specific patterns re-
lated to vesicular transport and secretion, and neurotrans-
mitters. We also observed differences in gene expression
changes caused by Chlamydia infection between our two
cell lines. It is well known that there are important differ-
ences in the luminal environments between the small andlarge intestines and we cannot exclude the influence of
cell origins on obtained results. We found many differ-
ences in basal gene transcriptions (non-infected cells) be-
tween the two cell lines but infected cells seem to share
the same genetic pattern independent of their origin.
Given the functions of EEC, it can be anticipated that
altered function, in the presence of disease, might under-
pin symptom development. EEC clearly have multiple
important functions in the control of appetite, GI motil-
ity and mucosal immunity. At present, EEC dysfunction
related to various GI diseases is acknowledged, but re-
mains poorly understood [43].
We do not have evidence that Chlamydia is the causa-
tive agent for motility disorders but we have shown that
such an infection can influence EEC function. We stud-
ied the response pattern of enteroendocrine cells to
intracellular bacteria in vitro using C. trachomatis as the
infectious agent. Our findings can serve as a model of
bacterial impact on EEC function but we cannot deter-
mine if our findings are Chlamydia specific or represent
a general response to intracellular infection. Infection of
mouse STC-1 enteroendocrine cells with Salmonella
typhimurium was recently reported [44]. We successfully
infected LCC18 with Salmonella typhimurium obtaining
intracellular growth of these bacteria in EEC, but we
have not analysed the effects of this infection on gene
expression.
Conclusions
Based on our findings that infected EEC exhibit cell-type
specific gene expression patterns related to vesicular
transport, secretion and neurotransmitter regulation our
study sheds some light on the potential impact of bac-
teria on the exocrine function of EEC. Since EEC play a
pivotal role in the regulation of gut motility any impair-
ment of enteroendocrine function could potentially con-
tribute to motility disorders.
Methods
Cell lines
We used two human enteroendocrine cell lines: LCC-18,
derived from a neuroendocrine colonic tumour (a kind
gift from K. Öberg, Uppsala University Hospital, Upp-
sala, Sweden); and CNDT-2, derived from a small intes-
tinal carcinoid (a kind gift from Lee M. Ellis, Dept. of
Surgical Oncology, The University of Texas, Houston,
TX, USA). LCC-18 cells were maintained in RPMI 1640
(Invitrogen, Life Technologies) supplemented with 5%
foetal bovine serum (FBS) (Hyclone, Thermo Scientific)
0.04 mg/ml transferrin (Sigma-Aldrich), 1.09 ng/ml b-
estradiol (Sigma-Aldrich), 100U/ml insulin (please add
supplier), 2.6 ng/ml hydrocortisone (Sigma-Aldrich),
30nM sodium selenite (Sigma-Aldrich,) and 25 mM
HEPES (Invitrogen, Life Technologies). CNDT-2 cells
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Life Technologies ) supplemented with 10% FBS, 1x MEM
vitamin solution (Gibco, Life Technologies), 2 mM L-glu-
tamine (Hyclone, Thermo Scientific) and 25 mM HEPES
(Invitrogen, Life Technologies) Both cell lines were grown
at 37°C in a 5% CO2 humidified environment. [7] LCC-18
are non-adherent and CNDT-2 cells grow adherent.
Chlamydial strains and infection conditions
Chlamydia trachomatis L2 strain 434 (ATCC) was prop-
agated in HeLa cells as previously described [45]. For in-
fection, LCC-18 and CNDT-2 cells were inoculated with
Chlamydia at a multiplicity of infection (MOI) of 0.5-1
for 1 h at 37°C. Monolayers of infected CNDT-2 cells
were washed with PBS (Phosphate buffered saline) and
incubated in fresh media media containing 8 μg/ml gen-
tamycin (Invitrogen, Life Technologies) for 24 h. In-
fected LCC-18 cells were spun at 500 x g for 5 min to
pellet the cells. The inoculum was removed and fresh
media containing 8 μg/ml gentamycin (Invitrogen) to kill
off extracellular bacteria was added. Infected LCC-18
cells were then incubated for 24 h. In order to induce
persistent infection, LCC-18 and CNDT-2 cells were in-
fected as described above and then incubated in medium
containing 100 U/ml penicillin G (penG) (Sigma-Al-
drich) for 24 h at 37°C.
Transmission electron microscopy (TEM)
Cells were grown in 6-well plates and infected with
Chlamydia trachomatis L2 in presence or absence of
penicillin G as described. At 24 h post infection the cells
were harvested, fixed in 0.1 M sodium cacodylate buffer
(pH 7.4) containing 2% glutaraldehyde, 0.5% parafor-
maldehyde, 0.1 M sucrose and 3 mM CaCl2 and prepared
for transmission electron microscopy as previously des-
cribed [46] and analysed in a BioTWIN (Fei, The
Netherlands). Digital images were obtained using a Veleta
digital camera (Soft Imaging System, Germany).
RNA extraction and microarray expression analysis
Total RNA was isolated from 1 x 106 LCC-18 and
CNDT-2 cells infected with Chlamydia trachomatis L2
(MOI 1) in presence or absence of penicillin G for 24 h.
RNA samples were prepared using the RNeasy Mini kit
(Qiagen) including an on-column DNase treatment step
according to the manufacturer´s instructions. RNA con-
centrations were measured with a ND-1000 spectropho-
tometer (NanoDrop Technologies, USA) and RNA
quality was assessed using the Agilent 2100 Bioanalyzer
(Agilent Technologies Inc, USA). 250 ng of total RNA
from each sample were used to generate amplified and
biotinylated cDNA according to the Ambion WT Expres-
sion Kit (P/N 4425209 Rev B 05/2009) and Affymetrix
GeneChip® WT Terminal Labeling and Hybridization UserManual (P/N 702808 Rev. 1, Affymetrix Inc., USA). Gene-
Chip® ST Arrays (GeneChip® Human Gene 1.0 ST Array)
were hybridized for 16 hours in a 45°C incubator, ro-
tated at 60 rpm. According to the GeneChip® Expres-
sion Wash, Stain and Scan Manual (PN 702731 Rev 2,
Affymetrix Inc., USA) the arrays were then washed and
stained using the Fluidics Station 450 and finally scanned
using the GeneChip® Scanner 3000 7G.
Microarray data analysis
Analysis of the gene expression data was carried out using
the freely available statistical computing software R
(http://www.r-project.org) using packages available from
the Bioconductor project (www.bioconductor.org). Raw
data was normalized using the robust multi-array average
(RMA) method first suggested by Li and Wong in 2001
[47,48]. In order to search for the differentially expressed
genes between acute and persistent infection and the con-
trol samples (non-infected) an empirical Bayes moderated
t-test [49] was applied using the ‘limma’ package [50]. The
p-values were adjusted for multiple comparisons using
the method of Benjamini and Hochberg [20]. Genes
with an expression ratio >2-fold and adjusted p < 0.05
were regarded as differentially transcribed genes [21].
Gene clustering based on Gene Ontology (GO) was per-
formed using the Database for Annotation, Visualization and
Integrated Discovery (DAVID) (http://david.abcc.ncifcrf.gov).
The data discussed in this publication have been de-
posited in NCBI's Gene Expression Omnibus [51] and
are accessible through GEO Series accession number
GSE58151 (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE58151).
Confirmation of microarray results by use of RT-PCR
To verify the microarray results, qPCR was carried out
on 10 genes coding for different solute carrier trans-
porters that were up- or down-regulated at 24 h after C.
trachomatis persistent infection of CNDT-2 and LCC-18
cells compared to non-infected.
Total RNA was isolated from 1 × 106 LCC-18 and
CNDT-2 cells (persistently infected at 24 h after in-
fection and non-infected cells, as prepared for the micro-
array experiment) by using the RNeasy Mini kit
(Qiagen) according to the manufacturer´s instructions.
RNA concentrations were measured with a ND-1000
spectrophotometer (NanoDrop Technologies, USA),
and 1,5 μg of total RNA was used for cDNA synthesis,
performed with the SuperScript First-Strand Synthesis
System (Invitrogen). Real-Time quantitative PCR (qPCR)
was carried out using TaqMan Gene Expression Assays
(Applied Biosystems) on 10 genes of interest (SLC1A4;
Hs00161719_m1, SLC5A3; Hs00272857_s1, SLC7A5;
Hs00185826_m1, SLC7A11; Hs00921938_m1, SLC16A6;
Hs00190779_m1, SLC25A10; Hs00201730_m1, SLC25A35;
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Hs00394339_m1, SLC41A2; Hs00259767_m1). PCRs were
performed in triplicate for each gene on the same sample,
and expression values normalized for the endogenous con-
trol GAPDH. Gene expression was calculated with the
comparative ΔΔCt method for relative quantification, and
expressed as fold changes (arbitrary units) relative to an ar-
bitrarily chosen reference sample.
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